Emergency Use Authorization of Covid Vaccines — Safety and Efficacy Follow-up Considerations

Philip R. Krause, Marion F. Gruber

New England Journal of Medicine · 2020 · 139 citations · 2 references

Concepts

Abstract

Emergency Use Authorization of Covid Vaccines A median 2-month follow-up after completion of an investigational Covid-19 vaccine regimen is necessary to provide safety and effectiveness data that s...

References

2